×
戻る Agenda
S27 : Preventing Misconduct Recurrence - Implementing Detection Mechanisms and Fostering an Environment that Deters Misconduct
Session Chair(s)
Kiyomi Hirayama, PHD
Senior Director, Quality Management Unit Japan Development, MSD K.K., Japan
Bei Yu, PHD
Pharmacologist, OSI, OC, CDER, FDA, United States
Speaker(s)
Hiroko Niwa
Inspection Director/Office of Non-Clinical and Clinical Compliance ?, Pharmaceuticals and Medical Devices Agency, Japan
Kayo Tamura
, Bristol Myers Squibb, Japan